Accomplished physician noted for research in gout, osteoarthritis etiology; characterizing therapeutic responsiveness in disease states; inspiring teamwork among rheumatologists
ACR Board of Directors Tackles Slate of Business at Annual Meeting
Board welcomes 233 new and returning candidates, lends support to lupus classification criteria in partnership with EULAR, approves update of ACR policy statements and position statements at February meeting in Napa, Calif.
President’s Perspective: The ACR and ARHP Advance Rheumatology Through International Collaboration
By forging new connections and strengthening efforts with global organizations such as EULAR, the College hopes to enhance the science, clinical care, and perceived value of rheumatology
Studies Show Promise for Scleroderma Therapy and Prediction of Progressing Disease
Research shows that a serum from goats might be helpful in combating diffuse cutaneous systemic sclerosis (SSc)
EULAR: Identify Arthritis Early, Treat it Effectively
Recent studies are uncovering genetic and environmental factors at play in the earliest stages of rheumatoid arthritis and medications that are effective in treating juvenile idiopathic arthritis
EULAR 2012: MicroRNAs’ Role in Rheumatic Diseases Coming into Sharper Focus
MicroRNAs are poised to play a big role in the future understanding and treatment of rheumatoid arthritis.
EULAR 2012: Rewards in Risk Factor Research
Investigations of infection and comorbidities offers hints to better understanding of rheumatoid arthritis.
EULAR 2012: Partnership Between Physician and Patient
Patient involvement a valuable tool, especially in less common rheumatic disorders.
EULAR 2012: Remission the New Normal for Rheumatoid Arthritis
Advances in the rheumatology clinic are promising, two experts say.
EULAR 2012: Systemic Sclerosis That Doesn’t Fit the Mold
This disease presents a range of hard-to-solve clinical difficulties.
- « Previous Page
- 1
- …
- 9
- 10
- 11
- 12
- 13
- Next Page »